BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16923467)

  • 1. Statin therapy for patients with chronic heart failure.
    Gong K; Song G; Zhang Z
    Am J Cardiol; 2006 Sep; 98(5):707. PubMed ID: 16923467
    [No Abstract]   [Full Text] [Related]  

  • 2. Statins and autonomic function in chronic heart failure.
    van der Harst P; Voors AA; van Gilst WH; van Veldhuisen DJ
    Cardiovasc Drugs Ther; 2005 May; 19(3):167-8. PubMed ID: 16142591
    [No Abstract]   [Full Text] [Related]  

  • 3. Atorvastatin therapy is associated with reduced levels of N-terminal prohormone brain natriuretic peptide and improved cardiac function in patients with heart failure.
    Stypmann J; Schubert A; Welp H; Schulte H; Assmann G; Breithardt G; Nofer JR
    Clin Cardiol; 2008 Oct; 31(10):478-81. PubMed ID: 18855352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroke--an equal opportunity for the initiation of statin therapy.
    Kent DM
    N Engl J Med; 2006 Aug; 355(6):613-5. PubMed ID: 16899782
    [No Abstract]   [Full Text] [Related]  

  • 5. Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure.
    Sola S; Mir MQ; Lerakis S; Tandon N; Khan BV
    J Am Coll Cardiol; 2006 Jan; 47(2):332-7. PubMed ID: 16412856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin pleiotropic effects mediated via suppression of TNF-alpha in congestive heart failure patients with initial normal TNF-alpha levels.
    Kotyla PJ
    J Heart Lung Transplant; 2009 Jan; 28(1):114-5. PubMed ID: 19134543
    [No Abstract]   [Full Text] [Related]  

  • 7. Does "anti-lipid" also mean "anti-arrhythmic"?
    Esberg D; Kowey P
    J Card Fail; 2005 Dec; 11(9):691-2. PubMed ID: 16360964
    [No Abstract]   [Full Text] [Related]  

  • 8. Usefulness of atorvastatin in patients with heart failure due to inflammatory dilated cardiomyopathy and elevated cholesterol levels.
    Wojnicz R; Wilczek K; Nowalany-Kozielska E; Szyguła-Jurkiewicz B; Nowak J; Poloński L; Dyrbuś K; Badziński A; Mercik G; Zembala M; Wodniecki J; Rozek MM
    Am J Cardiol; 2006 Mar; 97(6):899-904. PubMed ID: 16516598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide.
    Abulhul E; McDonald K; Martos R; Phelan D; Spiers JP; Hennessy M; Baugh J; Watson C; O'Loughlin C; Ledwidge M
    Clin Ther; 2012 Jan; 34(1):91-100. PubMed ID: 22154198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin therapy may reduce the incidence of sudden cardiac death in patients with advanced chronic heart failure.
    Vrtovec B; Okrajsek R; Golicnik A; Ferjan M; Starc V; Schlegel TT; Radovancevic B
    J Card Fail; 2008 Mar; 14(2):140-4. PubMed ID: 18325461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin therapy and the elderly: SAGE advice?
    Gotto AM
    Circulation; 2007 Feb; 115(6):681-3. PubMed ID: 17296867
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of atorvastatin on plasma levels of asymmetric dimethylarginine in patients with non-ischaemic heart failure.
    Young JM; Strey CH; George PM; Florkowski CM; Sies CW; Frampton CM; Scott RS
    Eur J Heart Fail; 2008 May; 10(5):463-6. PubMed ID: 18430606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase.
    Landmesser U; Engberding N; Bahlmann FH; Schaefer A; Wiencke A; Heineke A; Spiekermann S; Hilfiker-Kleiner D; Templin C; Kotlarz D; Mueller M; Fuchs M; Hornig B; Haller H; Drexler H
    Circulation; 2004 Oct; 110(14):1933-9. PubMed ID: 15466656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin, not rosuvastatin, improves cardiac function in heart failure: a meta-analysis of randomized trials.
    Takagi H; Umemoto T
    Int J Cardiol; 2012 Mar; 155(2):296-9. PubMed ID: 22200185
    [No Abstract]   [Full Text] [Related]  

  • 15. Atorvastatin and statins in the treatment of heart failure.
    Horwich TB; MacLellan WR
    Expert Opin Pharmacother; 2007 Dec; 8(17):3061-8. PubMed ID: 18001265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients.
    Oikonomou E; Siasos G; Zaromitidou M; Hatzis G; Mourouzis K; Chrysohoou C; Zisimos K; Mazaris S; Tourikis P; Athanasiou D; Stefanadis C; Papavassiliou AG; Tousoulis D
    Atherosclerosis; 2015 Feb; 238(2):159-64. PubMed ID: 25525743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin in nonischemic left ventricular systolic dysfunction.
    Bahl A; Chongtham DS
    J Am Coll Cardiol; 2006 Sep; 48(6):1283; author reply 1284. PubMed ID: 16979019
    [No Abstract]   [Full Text] [Related]  

  • 18. Cholesterol levels and the benefit of statins in heart failure.
    Lakoumentas JA; Dimitroula TG; Aggeli KI; Harbis PK
    Hellenic J Cardiol; 2005; 46(3):226-31. PubMed ID: 15981559
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study.
    Yamada T; Node K; Mine T; Morita T; Kioka H; Tsukamoto Y; Tamaki S; Masuda M; Okuda K; Fukunami M
    Am Heart J; 2007 Jun; 153(6):1055.e1-8. PubMed ID: 17540209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative statin therapy: understanding the evidence in a Bayesian context.
    Fleisher LA; Beattie WS
    Can J Anaesth; 2012 Jun; 59(6):511-5. PubMed ID: 22467069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.